UCPH-102 is a highly selective EAAT1 inhibitor with an IC50 value of 0.43 μM; it exhibits specific anti-proliferative effects on T-ALL cells and demonstrates good blood-brain barrier permeability, making it suitable for research in amyotrophic lateral sclerosis (ALS), Alzheimer's disease, chronic pain, and obsessive-compulsive disorder (OCD).